Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant - Top-Institutions - MDSpire

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

  • By

  • Suhaib Tawil

  • Nouraldeen Deeb

  • Wedad Alashwas

  • Hani Saleh

  • Khadra Salami

  • Alaa Jafar

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Children’s Minnesota
    Children’s Minnesota

    Minneapolis, Minnesota

    Key Differentiators

    • Pediatric Oncology

  • #2

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, Maryland

    Key Differentiators

    • Pediatric Oncology

  • #3

    Hospital for Sick Children
    Hospital for Sick Children

    Toronto, Ontario

    Key Differentiators

    • Pediatric Oncology

Original Source(s)

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

  • by Suhaib Tawil, Nouraldeen Deeb, Wedad Alashwas, Hani Saleh, Khadra Salami, Alaa Jafar

  • May 29, 2026

Related Content

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Potential targets for boron transport in boron neutron capture therapy

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation